Evaluation of sleep quality in rheumatoid arthritis patients

Basit Öğe Kaydı
dc.contributor.authorTuncay, Mehmet Siddik
dc.contributor.authorSahin, Ozlem
dc.contributor.authorSemiz, Murat
dc.contributor.authorSemiz, Esra
dc.contributor.authorAlim, Bulent
dc.contributor.authorPeksen, Halil
dc.contributor.authorSalihoglu, Salih
dc.date.accessioned2024-10-26T18:11:16Z
dc.date.available2024-10-26T18:11:16Z
dc.date.issued2024
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractAim: The purpose of this study was to evaluate treatment effects on sleep quality and fatigue in patients with RA. Besides, we aim to examine possible effects of disease activity, pain and socio-demographic features on sleep quality and fatigue. Material and Methods: In this study, 78 patients diagnosed with RA according to the American Rheumatism Association (ACR) 1987 revised criteria and European League Against Rheumatism (EULAR) criteria were compared with a parallel healthy control group (n=48). All participants were given a sociodemographic questionnaire, the Pittsburgh Sleep Quality Index (PSQI), Multidimensional Assessment of Fatigue Scale (MAF), Visual Analog Scale (VAS), Disease Activity Score 28 (DAS28). Results: The mean duration of diagnosis was 9.10 +/- 8.54 years and the mean score of DAS28 was 3.25 +/- 1.04 in patients with RA. In terms of total PSQI, the differences between two groups were found statistically significant (p=0.001; t=8.023). In terms of MAF, The differences between two groups were found statistically significant (p=0.001; t=3.668). The sleep disturbance and daytime functioning scores were found as 1.86 +/- 0.69, 1.40 +/- 0.83 respectively in nonbiological DMARD group and 1.54 +/- 0.66; 0.84 +/- 0.93 in biological + non -biological DMARD group. There were statistically significant differences between groups (p=0.043; t=2.054, p=0.008; t=2.730). According to correlation analysis between DAS28 and disease duration, a positive correlation has been found (r = 0.297; p = 0.008). Discussion: Patients with RA generally experience more fatigue and have worse sleep quality than healthy individuals. High disease activity can lead to longer sleep latency, reduced daytime functionality, and increased fatigue symptoms.
dc.identifier.doi10.4328/ACAM.22050
dc.identifier.endpage312
dc.identifier.issn2667-663X
dc.identifier.issue5
dc.identifier.startpage307
dc.identifier.urihttps://doi.org/10.4328/ACAM.22050
dc.identifier.urihttps://hdl.handle.net/20.500.12418/30575
dc.identifier.volume15
dc.identifier.wosWOS:001222910000011
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherBayrakol Medical Publisher
dc.relation.ispartofAnnals of Clinical and Analytical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRheumatoid Arthritis Pittsburgh Sleep Quality Index Multidimensional Assessment of Fatigue Scale Visual Analog Scale Disease Activity Score-28
dc.subjectPittsburgh Sleep Quality Index
dc.subjectMultidimensional Assessment of Fatigue Scale
dc.subjectVisual Analog Scale
dc.subjectDisease Activity Score-28
dc.titleEvaluation of sleep quality in rheumatoid arthritis patients
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu